Repros Therapeutics (RPRX) Outlines Specifics to Stay on NASDAQ Capital Market
Tweet Send to a Friend
Repros Therapeutics Inc. (NASDAQ: RPRX) today announced that Nasdaq has granted the Company until May 5, 2010 to meet the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
